We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDS.A
401
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $19.9M | 0.06% |
305,843
-1,162,257
| -79% | -$74.3M |
|
402
Becton Dickinson
BDX
$45.8B
| $19.8M | 0.06% |
80,360
-31,058
| -28% | -$7.22M |
|
403
TransDigm Group
TDG
$73.2B
| $19.8M | 0.06% |
40,837
+2,379
| +6% | +$1.11M |
|
404
Dollar General
DG
$27.8B
| $19.6M | 0.06% |
145,239
+8,454
| +6% | +$1.07M |
|
405
Healthcare Services Group
HCSG
$1.63B
| $19.5M | 0.06% |
643,204
+126,411
| +24% | +$4.18M |
|
406
The RealReal
REAL
$1.44B
| $19.2M | 0.06% |
+665,229
| New | +$19.2M |
|
407
Tapestry
TPR
$30.5B
| $19M | 0.06% |
599,700
-27,800
| -4% | -$867K |
|
408
Nasdaq
NDAQ
$53.6B
| $19M | 0.06% |
592,800
-232,800
| -28% | -$7.13M |
|
409
Columbus McKinnon
CMCO
$467M
| $18.7M | 0.06% |
444,438
-144,176
| -24% | -$5.49M |
|
410
SBA Communications
SBAC
$18.6B
| $18.6M | 0.06% |
82,849
-424
| -0.5% | -$89.5K |
|
411
General Mills
GIS
$20.1B
| $18.5M | 0.06% |
+352,300
| New | +$18.2M |
|
412
Zebra Technologies
ZBRA
$13.5B
| $18.5M | 0.06% |
88,103
-84,095
| -49% | -$17M |
|
413
Xcel Energy
XEL
$50.1B
| $18.2M | 0.06% |
306,300
+104,800
| +52% | +$6.03M |
|
|
CSFL
414
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $18.2M | 0.06% |
789,161
-859,268
| -52% | -$20.2M |
|
415
Republic Services
RSG
$66.6B
| $18.2M | 0.06% |
209,600
-11,700
| -5% | -$974K |
|
416
Carter's
CRI
$1.45B
| $18M | 0.06% |
184,809
+105,033
| +132% | +$10.2M |
|
|
MYOV
417
DELISTED
Myovant Sciences Ltd.
MYOV
| $17.9M | 0.06% |
1,974,460
+8,755
| +0.4% | +$131K |
|
|
EIDX
418
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $17.9M | 0.06% |
574,466
+286,244
| +99% | +$7.76M |
|
419
Huntington Ingalls Industries
HII
$11.8B
| $17.7M | 0.06% |
78,900
-71,100
| -47% | -$15.2M |
|
420
Arch Capital
ACGL
$37.2B
| $17.7M | 0.06% |
+477,915
| New | +$16.3M |
|
421
Oshkosh
OSK
$9.51B
| $17.6M | 0.06% |
+210,323
| New | +$16.6M |
|
422
Brown & Brown
BRO
$25B
| $17.4M | 0.06% |
+520,344
| New | +$16.5M |
|
423
Monolithic Power Systems
MPWR
$63B
| $17.4M | 0.06% |
128,265
-63,264
| -33% | -$8.6M |
|
|
CBM
424
DELISTED
Cambrex Corporation
CBM
| $17.2M | 0.06% |
366,864
-70,891
| -16% | -$2.97M |
|
425
Cincinnati Financial
CINF
$28.3B
| $17.1M | 0.06% |
+164,627
| New | +$15.8M |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.